NASDAQ:ACRS Investor Notice: Lawsuit Alleges Securities Laws Violations by Aclaris Therapeutics, Inc.
An investor, who purchased shares of Aclaris Therapeutics, Inc. (NASDAQ: ACRS), filed a lawsuit over alleged violations of Federal Securities Laws by Aclaris Therapeutics, Inc..
View full press release